Home › NDC Lookup › Ingredients › Coal Tar › 49758-0001-06
Dermabon Multi Symptom Psoriasis Control COAL TAR 21.3 mg/g Soap — NDC 49758-0001-06 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Dermabon Multi Symptom Psoriasis Control COAL TAR 21.3 mg/g Soap — NDC 49758-001-06 (Billing 49758-0001-06)

by Dermabon de Chihuahua, S.A. de C.V. · 6 BAG in 1 CARTON / 90 g in 1 BAG

This is a package of Dermabon Multi Symptom Psoriasis Control COAL TAR 21.3 mg/g Soap from Dermabon de Chihuahua, S.A. de C.V., marketed since Jul 2022 and currently FDA-listed, this package's marketing is listed to end Dec 2028.

NDC 49758-0001-06
🏷️ FDA NDC (as labeled) 49758-001-06 billing pads the product segment with a zero
This package
Contains90 g in 1 bag Pack sizes3 compare ↓
Product page 49758-0001-01 Also comes in: 90 g 49758-001-01 90 g 49758-001-03
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 49758-001-06 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
49758 labeler · 001 product · 06 package
Package marketed since
Jul 1, 2022
Package marketing ended
Dec 31, 2028
Sample package
No — commercial package
Barcode (UPC)
7502310310099
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 49758-001-06
Product NDC 49758-001
11-digit billing NDC 49758000106
RxCUI 1038967
UNII R533ESO2EC
UPC 7502310310099
Application # M032
SPL Set ID d5b739ba-e332-41f6-9343-6ad5cc981344
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2022-07-01
Marketing end 2028-12-31
Route TOPICAL
Dosage form SOAP
Substance COAL TAR
Quick answers
  • RxCUI (RxNorm): 1038967
Why two NDCs? The FDA registers this code as 49758-001-06 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 49758-0001-06. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

📗 Our plain-language guide HelloPharmacist
  • It relieves the itching, scaling, flaking and redness of psoriasis, seborrheic dermatitis and dandruff. Which of these a product treats depends on the brand, so check your package....
  • It depends on the product. Most coal tar shampoos say to use them at least twice a week, leaving the lather on for several minutes. Some ointments, gels and lotions can be used one...
  • Be careful. Coal tar can make you more likely to sunburn for up to 24 hours after you apply it. Cover up and limit sun exposure during that time.
  • Don't combine it with light therapy or prescription psoriasis medicines unless your doctor says it's okay. Check with me or your doctor first if you're not sure.
📖 Read our full Coal Tar guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 90 g 90 g
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
49758-0001-01 49758-001-01 Main listing 1 BAG in 1 CARTON / 90 g in 1 BAG 2022-07-01 Dec 31, 2028 Active
49758-0001-03 49758-001-03 3 BAG in 1 CARTON / 90 g in 1 BAG 2022-07-01 Dec 31, 2028 Active
49758-0001-06 You're viewing this 6 BAG in 1 CARTON / 90 g in 1 BAG 2022-07-01 Dec 31, 2028 Active

Pack size FAQ

What quantity is in this package?
This package is listed by the FDA — 6 bag in 1 carton / 90 g in 1 bag.
What NDC number is used to bill for this package of Dermabon Multi Symptom Psoriasis Control COAL TAR 21.3 mg/g Soap?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Dermabon Multi Symptom Psoriasis Control 21.3 mg/gthis 49758-0001-06 Dermabon 90 g — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2022
On the market since
Jul 2022
📍
2026
Currently FDA-listed
4 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Coal Tar inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII H4N855PNZ1
    Alpha-tocopherol is a form of vitamin E, a fat-soluble antioxidant derived from natural or synthetic sources. In medicines, it prevents oils and fats from breaking down and becoming rancid, protecting the product's stability and shelf life.
  • UNII 3K9958V90M
    A liquid solvent derived from fermentation or chemical synthesis. In medicines, alcohol dissolves active ingredients, helps preserve the product, and improves how the body absorbs certain drugs.
  • UNII PDC6A3C0OX
    Glycerin is a clear, thick liquid derived from plant oils or fats. It acts as a humectant to retain moisture, a sweetener, and a solvent in medications.
  • UNII 230OU9XXE4
    A waxy substance made from glycerin and stearic acid that acts as an emulsifier to blend oily and watery ingredients together. It also helps thicken and stabilize the medicine's texture.
  • UNII 7EV65EAW6H
    Lanolin is a waxy substance derived from sheep's wool. It's used in medicines as an emollient and skin-conditioning agent to soften formulations and improve spreadability in topical products like creams and ointments.
  • UNII A2I8C7HI9T
    Methylparaben is a preservative derived from benzoic acid that prevents growth of bacteria, fungi, and mold in medicines. It extends the product's shelf life and maintains safety during storage.
  • UNII 91MBZ8H3QO
    Sodium borate is an inorganic salt compound used in medicines as a buffer to help maintain a stable pH level, and sometimes as a mild preservative or cleansing agent in topical formulations.
  • UNII DY38VHM5OD
    Sodium hypochlorite is a chemical compound commonly used as a disinfectant and antimicrobial agent. In medicines, it may serve as a preservative or antimicrobial component to help prevent bacterial growth and contamination in the product.
  • UNII 4ELV7Z65AP
    Stearic acid is a fatty acid derived from plant or animal sources. It acts as a binder and lubricant in tablets and capsules, helping them hold together and flow smoothly during manufacturing.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

10 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesBorax, Ethyl Alcohol, Glycerin, Glyceryl Stearate, Lanolin, Methylparaben, Sodium Hypoochlorite, Stearic Acid, Petrolatum Oil, Vitamin E, Soap base and Water.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerDermabon de Chihuahua, S.A. de C.V.
FDA applicationM032 (OTC MONOGRAPH DRUG)
Labeler code49758
First marketedJul 2022
Product typeHuman Otc Drug
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 8 words ▾

Uses For the relief of psoriasis and dandruff

⏱️ Dosage and Administration 10 words ▾

Directions Apply in affected areas, let it rest, and rinse.

⚠️ Warnings 117 words ▾

Warnings For external use only. Avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water.

If condition worsens or does not improve after regular use of this product as directed, consult a doctor. Use caution when exposing skin to sunlight after applying this product, it may increase your tendency to sunburn up to 24 hours after application. Do not use for prolonged periods without consulting a doctor. do not use this proudct with other forms of psoriasis therapy, such as ultraviolet radiation or prescription drugs, unless directed to do so by a doctor.

If condition covers a large area of the body, consult your doctor before using this product. Keep out of reach of children.

🧪 Active Ingredient 10 words ▾

Active Ingredients Coal Tar / 2.13% Purposes Anti-Psoriasis / Anti-Dandruff

🧪 Inactive Ingredients 22 words ▾

Inactive Ingredients Borax, Ethyl Alcohol, Glycerin, Glyceryl Stearate, Lanolin, Methylparaben, Sodium Hypoochlorite, Stearic Acid, Petrolatum Oil, Vitamin E, Soap base and Water.

🎯 Purpose 4 words ▾

Purposes Anti-Psoriasis / Anti-Dandruff

📄 Do Not Use 52 words ▾

Do not use for prolonged periods without consulting a doctor. do not use this proudct with other forms of psoriasis therapy, such as ultraviolet radiation or prescription drugs, unless directed to do so by a doctor. If condition covers a large area of the body, consult your doctor before using this product.

📄 Keep Out of Reach of Children 6 words ▾

Keep out of reach of children.

📄 Package Label / Principal Display Panel 5 words ▾

Package Labeling: Label

Shampoo Label

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Dermabon Multi Symptom Psoriasis Control (this brand).

Top reported reactions

Psoriasis420
Malaise300
Fatigue267
Pain252
Nasopharyngitis236
Skin Exfoliation227
Fall223

Reporter sex

757 reports

Serious outcomes

Life-threatening244
Disabling132
Death13
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 113 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page it is currently marketed — but Dermabon de Chihuahua, S.A. de C.V. has reported a marketing end date of 2028-12-31, after which this package is expected to stop being marketed. The directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 2 other package presentations of this same product, including 90 g (49758-0001-01), 90 g (49758-0001-03). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Dermabon de Chihuahua, S.A. de C.V. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 49757-0114-02 · Rocky 49766-2858-01 · Max's →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.